Simon’s Blog

A couple of days, I wrote about my predictions for the return of the VC-backed drug discovery biotech technology platform company. Yesterday, there was another major acquisition of a small biotech company by a large pharmaceutical company. So, there are now several reasons why I’m expecting a flurry of VC activity in the [...]

A couple of weeks ago, we met with one of the leading venture capital groups to talk about life sciences. The purpose of the meeting was to talk about what’s really going in the hottest biotech start-ups at the moment (as with many industries, there’s so much hype around, that what is heard [...]